BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/15/2019 10:30:02 AM | Browse: 836 | Download: 1524
 |
Received |
|
2019-02-20 07:29 |
|
Peer-Review Started |
|
2019-02-22 09:02 |
|
To Make the First Decision |
|
2019-04-16 06:31 |
|
Return for Revision |
|
2019-04-17 08:52 |
|
Revised |
|
2019-04-17 12:35 |
|
Second Decision |
|
2019-05-27 08:14 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-05-29 17:48 |
|
Articles in Press |
|
2019-05-29 17:48 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-07-15 07:57 |
|
Publish the Manuscript Online |
|
2019-07-15 10:30 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Recent progress of chemotherapy and biomarkers for gastroesophageal cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Osamu Maeda and Yuichi Ando |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Osamu Maeda, MD, PhD, Lecturer, Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan. maeda-o@med.nagoya-u.ac.jp |
| Key Words |
Gastroesophageal cancer; Chemotherapy; Biomarker; HER2 |
| Core Tip |
This article reviewed the current status and recent developments of gastroesophageal cancer and its related biomarkers for treatment selection. Platinum, fluoropyrimidines, taxanes, irinotecan, trastuzumab and ramucirumab are key drugs. Recently, anti-PD-1 antibodies have become available. PD-L1 expression and microsatellite instability are used to predict the effectiveness of immunotherapy. Genome-wide analysis will provide a better understanding of the biology in gastroesophageal cancer. |
| Publish Date |
2019-07-15 10:30 |
| Citation |
Maeda O, Ando Y. Recent progress of chemotherapy and biomarkers for gastroesophageal cancer. World J Gastrointest Oncol 2019; 11(7): 518-526 |
| URL |
https://www.wjgnet.com/1948-5204/full/v11/i7/518.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v11.i7.518 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
